NCT04645706View on ClinicalTrials.gov

Innate T Cells and TKI Discontinuation

Active, not recruitingOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Chronic Myeloid Leukemia
Interventions
OTHER

Characteristics of innate T cells

functional and phenotypic characteristics of innate T cells

Trial Locations (1)

86000

C.H.U. de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER